Asset Details
Do you wish to reserve the book?
2746 Developing a quality assurance framework for neuro-ophthalmology using the Neuro-Ophthalmology Database (NODE)
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
2746 Developing a quality assurance framework for neuro-ophthalmology using the Neuro-Ophthalmology Database (NODE)
Do you wish to request the book?
2746 Developing a quality assurance framework for neuro-ophthalmology using the Neuro-Ophthalmology Database (NODE)
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
2746 Developing a quality assurance framework for neuro-ophthalmology using the Neuro-Ophthalmology Database (NODE)
2023
Overview
ObjectivesQuality assurance (QA) in neuro-ophthalmology (NOPH) is often lacking. We aimed to assess the quality of referral assessment and time-to-consult for common neuro-ophthalmological conditions by implementing a QA registry, NODE (Neuro-ophthalmology Database) in a tertiary Neuro-ophthalmology clinic. Australian standardised triage categories; P1 (consult<=30 days), P2 (consult<=30 to 60 days) and P3 (consult>60 days) were developed and validated for neuro-ophthalmological conditions.MethodsWe collected data in NODE on 676 patients at Alfred Hospital, Melbourne and developed a consensus on the assignation of NOPH conditions to triage categories using a modified Delphi Approach with a panel of seven experienced neuro-ophthalmologists. We analysed the mean days from referral to triage, and from triage to initial consultation and compared these to the Australian standardised triage categories.ResultsCommon diagnoses were Idiopathic Intracranial Hypertension, IIH (19%), Optic Neuropathy, ON (14%), Non-specific Headaches, (11%) Cranial Nerve Defects, CND (8%) and Papilloedema (7%). The mean time from referral to triage was <5 days for all the common diagnoses. The mean days (±standard deviation (SD)) from P1 category triage to initial consult for IIH was 15 (±12), Acute ON 16 (±14), and CND was 20 (±15). For P2 triage-to-consult for Papilloedema was 20 (±19), non-specific Headaches was 22 (±20), and EOMD was 48 (±22). For P3 triage-to-consultant for Non-ocular Myasthenia Gravis was 38 days (±29) and for Visual Snow was 54 (±31 days).ConclusionsWe established a NOPH registry that will serve as a framework to benchmark quality of care between NOPH services and improve clinical outcomes for patients.
Publisher
BMJ Publishing Group Ltd,BMJ Publishing Group LTD
Subject
